XML 40 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2018
Disclosure Of Share based Payment Arrangements Explanatory [Abstract]  
Disclosure of share-based payment arrangements [text block]
Note 19.
Share-Based Compensation
 
The amounts of share-based compensation expenses included in applicable costs of sales and expense categories and related tax effects are summarized as follows:
 
  
Year ended December 31,
 
  
2017
  
2018
 
  
(in thousands)
 
       
Cost of revenues $204   90 
Research and development  5,222   3,165 
General and administrative  723   387 
Sales and marketing  995   544 
Total compensation recognized in income 
$
7,144
   
4,186
 
Income tax benefit 
$
1,525
   
894
 
 
(a)Long-term Incentive Plan
 
On September 7, 2011, the Company’s shareholders approved a long-term incentive plan. The plan was amended and restated by extending its duration to September 6, 2019, which was approved by the Company’s shareholders at the annual general meeting held on August 31, 2016. The plan permits the grants of options or RSUs to the Company’s employees, directors and service providers where each unit of RSU represents two ordinary shares of the Company.
 
On September 26, 2014, the Company’s compensation committee made grants of 1,219,791 RSUs to the Company’s employees. The vesting schedule for the RSUs is as follows: 82.57% of the RSUs grant vested immediately on the grant date which was settled by cash amounting to $9,337 thousand, a subsequent 5.81% will vest on each of September 30, 2015, 2016 and 2017 which will be settled by the Company’s ordinary shares, subject to certain forfeiture events.
 
On September 25, 2015, the Company’s compensation committee made grants of 597,596 RSUs to the Company’s employees. The vesting schedule for the RSUs is as follows: 94.15% of the RSUs grant vested immediately on the grant date which was settled by cash amounting to $4,456 thousand, a subsequent 1.95% will vest on each of September 30, 2016, 2017 and 2018 which will be settled by the Company’s ordinary shares, subject to certain forfeiture events.
 
On September 28, 2016, the Company’s compensation committee made grants of 1,208,785 RSUs to the Company’s employees. The vesting schedule for the RSUs is as follows: 91.93% of the RSUs grant vested immediately on the grant date which was settled by cash amounting to $9,223 thousand, a subsequent 2.69% will vest on each of September 30, 2017, 2018 and 2019 which will be settled by the Company’s ordinary shares, subject to certain forfeiture events.
 
On September 29, 2017, the Company’s compensation committee made grants of 580,235 RSUs to the Company’s employees. The vesting schedule for the RSUs is as follows: 96.91% of the RSUs grant vested immediately on the grant date which was settled by cash amounting to $6,147 thousand, a subsequent 1.03% will vest on each of September 30, 2018, 2019 and 2020 which will be settled by the Company’s ordinary shares, subject to certain forfeiture events.
 
On September 26, 2018, the Company’s compensation committee made grants of 676,273 RSUs to the Company’s employees. The vesting schedule for the RSUs is as follows: 97.15% of the RSUs grant vested immediately on the grant date which was settled by cash amounting to $3,778 thousand, a subsequent 0.95% will vest on each of September 30, 2019, 2020 and 2021 which will be settled by the Company’s ordinary shares, subject to certain forfeiture events.
 
The amount of compensation expense from the long-term incentive plan was determined based on the estimated fair value and the market price of ADS (one ADS represents two ordinary shares) underlying the RSUs granted on the date of grant, which were $9.27 per ADS, $7.92 per ADS, $8.30 per ADS, $10.93 per ADS and $5.76 per ADS on September 26, 2014, September 25, 2015, September 28, 2016, September 29, 2017 and September 26, 2018, respectively.
 
RSUs activity under the long-term incentive plan during the periods indicated is as follows:
 
  
Number of
Underlying
Shares for RSUs
  
Weighted
Average Grant
Date Fair Value
 
       
Balance at January 1, 2017  182,488  $8.60 
Granted  580,235   10.93 
Vested  (662,368)  10.62 
Forfeited  (7,755)  8.77 
Balance at December 31, 2017  92,600   8.77 
Granted  676,273   5.76 
Vested  (698,427)  5.92 
Forfeited  (10,108)  8.55 
Balance at December 31, 2018  
60,338
   7.98 
 
As of December 31, 2018, the total compensation cost related to the unvested RSUs not yet recognized was $294 thousand. The weighted-average period over which it is expected to be recognized is 1.58 years.
 
In 2017 and 2018, the Company settled RSUs release with shares buyback of 200,074 shares and 82,814 shares, respectively.
 
The allocation of compensation expenses and related tax effects from the RSUs granted to employees under the long-term incentive plan are summarized as follows:
 
  
Year ended December 31,
 
  
2017
  
2018
 
  
(in thousands)
 
Cost of revenues $112   56 
Research and development  5,097   3,104 
General and administrative  686   373 
Sales and marketing  980   538 
Total compensation from RSUs 
$
6,875
   
4,071
 
Income tax benefit 
$
1,525
   
894
 
 
(b)Employee stock options
 
(i)On January 1, 2016, board of directors of Himax Imaging, Inc. approved a plan to grant stock options, the 2016 plan, to certain employees. The 2016 plan authorizes grants to purchase up to 1,760,000 shares of Imaging Taiwan’ issued ordinary shares held by Himax Imaging, Inc. The exercise price was NT$30 (US$0.9139). Himax Taiwan obtained all Imaging Taiwan’ issued ordinary shares previously held by Himax Imaging, Inc. in March, 2017, in a re-organization of entities under common control, whereby Himax Taiwan assumed the obligation to sell Imaging Taiwan’ ordinary shares once employees exercised the options for the 2016 plan.
 
The 2016 plan has four years contractual life and three years vesting period. Based on the vesting schedule, 50% of the options vest one and half years after the date of grant and 50% of the options vest three years after the date of grant. Because the exercise price of the options are higher than the estimated fair value of Imaging Taiwan shares at the date of grant, the calculated value of each option award estimated using the Black-Scholes option-pricing model was nil.
 
The calculated value of option award is estimated on the date of grant using the Black-Scholes option-pricing model that used the weighted average assumptions in the following table. Himax Imaging, Inc. uses the simplified method to estimate the expected term of the options as it does not have sufficient historical share option exercise experience and the exercise data relating to employees of other companies is not easily obtainable. Since Imaging Taiwan’ shares are not publicly traded and its shares are rarely traded privately, expected volatility is computed based on the average historical volatility of similar entities with publicly traded shares. The risk-free rates for the expected term of the option are based on the interest rates of 2 years and 5 years ROC central government bond at the time of grant.
 
  
2016 plan
 
Valuation assumptions:    
Expected dividend yield  0%
Expected volatility  38.04%
Expected term (years)  3.125 
Risk-free interest rate  0.50%
 
Stock option activity during the periods indicated is as follows:
 
  
Number

of shares
  
Weighted
average

exercise 

price
  
Weighted

average

remaining

contractual

term
 
          
Balance at January 1, 2017  616,000  $0.9139   3.0 
Granted  -   -     
Exercised  -   -     
Forfeited  (35,000)  0.9139     
Balance at December 31, 2017  581,000   0.9139   2.0 
Granted  -   -     
Exercised  -   -     
Forfeited  (35,000)  0.9139     
Balance at December 31, 2018  
546,000
   0.9139   1.0 
Exercisable at December 31, 2018  
285,500
   0.9139     
 
(ii)On January 1, 2016, board of directors of Imaging Taiwan approved a plan to grant stock options, the 2016 plan, to certain employees. This plan authorizes grants to purchase up to 2,040,000 shares of Imaging Taiwan’ authorized but unissued ordinary shares. The exercise price was NT$30 (US$0.9139).
 
The 2016 plan has four years contractual life and three years vesting period. Based on the vesting schedule, 50% of the options vest one and half years after the date of grant and 50% of the options vest three years after the date of grant. Because the exercise price of the options are higher than the estimated fair value of Imaging Taiwan shares at the date of grant, the calculated value of each option award estimated using the Black-Scholes option-pricing model was nil.
 
The calculated value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that used the weighted average assumptions in the following table. Imaging Taiwan uses the simplified method to estimate the expected term of the options as it does not have sufficient historical share option exercise experience and the exercise data relating to employees of other companies is not easily obtainable. Since Imaging Taiwan’ shares are not publicly traded and its shares are rarely traded privately, expected volatility is computed based on the average historical volatility of similar entities with publicly traded shares. The risk-free rates for the expected term of the options are based on the interest rates of 2 years and 5 years ROC central government bond at the time of grant.
 
  
2016 plan
 
Valuation assumptions:    
Expected dividend yield  0%
Expected volatility  38.04%
Expected term (years)  3.125 
Risk-free interest rate  0.50%
 
Stock option activity during the periods indicated is as follows:
 
  
Number

of shares
  
Weighted

average

exercise 

price
  
Weighted

average

remaining

contractual

term
 
          
Balance at January 1, 2017  1,797,000  $0.9139   3.0 
Granted  -   -     
Exercised  (115,000)  0.9139     
Forfeited  (173,000)  0.9139     
Balance at December 31, 2017  1,509,000   0.9139   2.0 
Granted  -   -     
Exercised  -   -     
Forfeited  (150,000)  0.9139     
Balance at December 31, 2018  
1,359,000
   0.9139   1.0 
Exercisable at December 31, 2018  
645,000
   0.9139     
 
(iii)On October 6, 2015, board of directors of Himax Display, Inc. approved a plan to grant stock options, the 2015 plan, to certain employees. This plan authorizes grants to purchase up to 2,528,000 shares of Himax Display, Inc.’ authorized but unissued ordinary shares. The exercise price was NT$65 (US$1.986).
 
The 2015 plan has four years contractual life and three years vesting period. Based on the vesting schedule, 50% of the options vest one and half years after the date of grant and 50% of the options vest three years after the date of grant. The Company recognized compensation expenses of $269 thousand and $115 thousand in 2017 and 2018, respectively. Such compensation expense was recorded as cost of revenues, sales and marketing expenses, general and administrative expenses and research and development expenses in the consolidated statements of profit or loss. There was no income tax benefit realized in the consolidated statements of profit or loss for employee stock options for the years ended December 31, 2017 and 2018.
 
The calculated value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that used the weighted average assumptions in the following table. Himax Display, Inc. uses the simplified method to estimate the expected term of the options as it does not have sufficient historical share option exercise experience and the exercise data relating to employees of other companies is not easily obtainable. Since Himax Display, Inc.’ shares are not publicly traded and its shares are rarely traded privately, expected volatility is computed based on the average historical volatility of similar entities with publicly traded shares. The risk-free rate for the expected term of the options is based on the interest rates of 2 years and 5 years ROC central government bond at the time of grant.
 
  
2015 plan
 
Valuation assumptions:    
Expected dividend yield  0%
Expected volatility  33.52%
Expected term (years)  3.125 
Risk-free interest rate  0.65%
  
Stock option activity during the periods indicated is as follows:
 
  
Number
of shares
  
Weighted
 

average
 

exercise
 

price
  
Weighted
 

average
 

remaining
 

contractual
 

term
 
          
Balance at January 1, 2017  1,993,000  $
1.986
   2.75 
Granted  -   -     
Exercised  -   -     
Forfeited  (50,000)  1.986     
Balance at December 31, 2017  1,943,000   1.986   1.75 
Granted  -   -     
Exercised  -   -     
Forfeited  (32,000)  1.986     
Balance at December 31, 2018  
1,911,000
   1.986   0.75 
Exercisable at December 31, 2018  
1,911,000
   1.986